dsdsa ua

khoom

Sab saum toj Zoo Peptide Powder 83150-76-9 Octreotide acetate Rau Tumor Treatment

Lus piav qhia luv luv:


  • Purity:≧98.0% hmoov dawb
  • Muaj peev xwm:5Kg / hli
  • Daim ntawv pov thawj:COA, HPLC.
  • Lub neej txee:peb xyoos
  • Daim ntawv thov:Siv los kho mob raws plab heev thiab sai li sai tau reddening ntawm lub ntsej muag thiab caj dab los ntawm qee hom qog
  • Pab Pawg Advantage:Kev paub export pab neeg muag khoom nrog kev cob qhia hauv lub hoobkas
  • Product Detail

    FAQ

    Khoom cim npe

    Khoom npe

    Octreotide acetate hmoov

    Ib ntus

    [R-(R*,R*)]-D-Phenylalanyl-L-cysteineyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)] propyl]-cysteamide cyclic (2-> 7)-disulfide

    MOQ

    1G

    CAS Nr.

    83150-76-9

    Qhov tshwm sim

    hmoov dawb

    Molecular Formula

    C49H66N10O10S2.2 (C2H4O2)

    Molecular Luj

    1139.35 Nws

    Assay

    99%

    Daim ntawv thov

    Pharma qib rau kev tshawb fawb

    Ntim

    Raws li koj qhov kev thov

    Cia

    Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias

    Lus hais

    NA

    Kev cai synthesis

    Muaj

    Muaj peev xwm muab khoom

    1 kg / hli

    Cov ntaub ntawv tuam txhab

    √ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm;
    √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system;
    √ 11 xyoo dhau los ntawm pab pawg muag khoom;
    √ Kev ywj pheej R & D lab;
    √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia;
    √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized;
    √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.
    imgsaf uaSDGSHDASFG

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb